Diabetic patients are at high risk for mortality after contracting several infections. Additionally, diabetes has been mentioned as an independent factor for progression to severe disease in seasonal influenza and in-hospital deaths due to coronavirus 2019 (COVID-19). Diabetic ketoacidosis is a well-known complication of type-1 diabetes and is characterized by hyperglycemia, metabolic acidosis, and high ketone levels. Euglycemic diabetic ketoacidosis (EDK) is a rare variant of diabetic ketoacidosis in which the blood glucose levels remain within normal limits, but ketoacidosis develops. Although EDK has often been associated with the use of sodium–glucose transport-2 (SGLT-2) inhibitors, it can be induced by several factors, including infectious diseases. EDK may present during the course of an infection, and it also can be a manifestation indicating infection. In this report, two cases of EDK due to pneumonia caused by two different pathogens are presented. Moreover, it is important to emphasize that EDK can occur in type-1 diabetic patients who are not using SGLT-2 inhibitors. Additionally, EDK can be a manifestation of infection and a possible marker of progression to severe disease in patients with type 1 diabetes.
Acidosis, COVID-19, Diabetic ketoacidosis, Euglycemia, Ketosis, Pneumonia
Primary Language | English |
---|---|
Subjects | Emergency Medicine, Endocrinology and Metabolism, Critical Care Medicine |
Journal Section | Case report |
Authors |
|
Publication Date | April 1, 2022 |
Published in Issue | Year 2022, Volume 6, Issue 4 |
Bibtex | @case report { josam979687, journal = {Journal of Surgery and Medicine}, issn = {}, eissn = {2602-2079}, address = {jsurgmed@gmail.com}, publisher = {Fatih BAŞAK}, year = {2022}, volume = {6}, pages = {519 - 520}, doi = {10.28982/josam.979687}, title = {SARS-CoV-2 and community-acquired pneumonia leading to euglycemic diabetic ketoacidosis in two patients with type-1 diabetes mellitus who were not using SGLT2 inhibitors}, key = {cite}, author = {Telci Çaklılı, Özge and Gürbüz, Hande} } |
APA | Telci Çaklılı, Ö. & Gürbüz, H. (2022). SARS-CoV-2 and community-acquired pneumonia leading to euglycemic diabetic ketoacidosis in two patients with type-1 diabetes mellitus who were not using SGLT2 inhibitors . Journal of Surgery and Medicine , 6 (4) , 519-520 . DOI: 10.28982/josam.979687 |
MLA | Telci Çaklılı, Ö. , Gürbüz, H. "SARS-CoV-2 and community-acquired pneumonia leading to euglycemic diabetic ketoacidosis in two patients with type-1 diabetes mellitus who were not using SGLT2 inhibitors" . Journal of Surgery and Medicine 6 (2022 ): 519-520 <https://jsurgmed.com/en/pub/issue/69115/979687> |
Chicago | Telci Çaklılı, Ö. , Gürbüz, H. "SARS-CoV-2 and community-acquired pneumonia leading to euglycemic diabetic ketoacidosis in two patients with type-1 diabetes mellitus who were not using SGLT2 inhibitors". Journal of Surgery and Medicine 6 (2022 ): 519-520 |
RIS | TY - JOUR T1 - SARS-CoV-2 and community-acquired pneumonia leading to euglycemic diabetic ketoacidosis in two patients with type-1 diabetes mellitus who were not using SGLT2 inhibitors AU - Özge Telci Çaklılı , Hande Gürbüz Y1 - 2022 PY - 2022 N1 - doi: 10.28982/josam.979687 DO - 10.28982/josam.979687 T2 - Journal of Surgery and Medicine JF - Journal JO - JOR SP - 519 EP - 520 VL - 6 IS - 4 SN - -2602-2079 M3 - doi: 10.28982/josam.979687 UR - https://doi.org/10.28982/josam.979687 Y2 - 2022 ER - |
EndNote | %0 Journal of Surgery and Medicine SARS-CoV-2 and community-acquired pneumonia leading to euglycemic diabetic ketoacidosis in two patients with type-1 diabetes mellitus who were not using SGLT2 inhibitors %A Özge Telci Çaklılı , Hande Gürbüz %T SARS-CoV-2 and community-acquired pneumonia leading to euglycemic diabetic ketoacidosis in two patients with type-1 diabetes mellitus who were not using SGLT2 inhibitors %D 2022 %J Journal of Surgery and Medicine %P -2602-2079 %V 6 %N 4 %R doi: 10.28982/josam.979687 %U 10.28982/josam.979687 |
ISNAD | Telci Çaklılı, Özge , Gürbüz, Hande . "SARS-CoV-2 and community-acquired pneumonia leading to euglycemic diabetic ketoacidosis in two patients with type-1 diabetes mellitus who were not using SGLT2 inhibitors". Journal of Surgery and Medicine 6 / 4 (April 2022): 519-520 . https://doi.org/10.28982/josam.979687 |
AMA | Telci Çaklılı Ö. , Gürbüz H. SARS-CoV-2 and community-acquired pneumonia leading to euglycemic diabetic ketoacidosis in two patients with type-1 diabetes mellitus who were not using SGLT2 inhibitors. J Surg Med. 2022; 6(4): 519-520. |
Vancouver | Telci Çaklılı Ö. , Gürbüz H. SARS-CoV-2 and community-acquired pneumonia leading to euglycemic diabetic ketoacidosis in two patients with type-1 diabetes mellitus who were not using SGLT2 inhibitors. Journal of Surgery and Medicine. 2022; 6(4): 519-520. |
IEEE | Ö. Telci Çaklılı and H. Gürbüz , "SARS-CoV-2 and community-acquired pneumonia leading to euglycemic diabetic ketoacidosis in two patients with type-1 diabetes mellitus who were not using SGLT2 inhibitors", Journal of Surgery and Medicine, vol. 6, no. 4, pp. 519-520, Apr. 2022, doi:10.28982/josam.979687 |